Showing results (111-120 of 213) with videos related to
Sort By:
Pageof 22
Cerebrovascular Diseases (Basel, Switzerland)|April 15, 2015
Incident cancer in a cohort of 3,247 cancer diagnosis free ischemic stroke patientsAdnan I Qureshi, Ahmed A Malik, Omar Saeed, et al.The American Journal of Emergency Medicine|September 6, 2014
Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic reviewAdnan I Qureshi, Ahmed A Malik, Melissa Freese, et al.Cerebrovascular Diseases Extra|April 10, 2012
Outcome of the 'Drip-and-Ship' Paradigm among Patients with Acute Ischemic Stroke: Results of a Statewide StudyAdnan I Qureshi, Saqib A Chaudhry, Gustavo J Rodriguez, et al.Accident; Analysis and Prevention|September 10, 2020
Mandated societal lockdown and road traffic accidentsAdnan I Qureshi, Wei Huang, Suleman Khan, et al.Journal of Neurointerventional Surgery|June 4, 2025
Timing of intracranial stent placement and one month stroke and/or death rates in patients with high-grade symptomatic intracranial stenosis: pooled analysis of SAMMPRIS and VISSIT trialsAdnan I Qureshi, Yilun Huang, Ameer E Hassan, et al.Neurocritical Care|July 24, 2010
Occurrence of post-acute recanalization and collateral formation in patients with cerebral venous and sinus thrombosis. A serial venographic studyAbeer Farrag, Muna Irfan, Gaurav K Guliani, et al.Stroke|June 7, 2012
Drip-and-ship thrombolytic treatment paradigm among acute ischemic stroke patients in the United StatesWondwossen G Tekle, Saqib A Chaudhry, Ameer E Hassan, et al.Neurocritical Care|October 14, 2011
Increased rate of aspiration pneumonia and poor discharge outcome among acute ischemic stroke patients following intubation for endovascular treatmentAmeer E Hassan, Saqib A Chaudhry, Haralabos Zacharatos, et al.Neurosurgery|March 3, 2012
Rate of postprocedural stroke and death in SAMMPRIS trial-eligible patients treated with intracranial angioplasty and/or stent placement in practiceFarhan Siddiq, Saqib A Chaudhry, Rakesh Khatri, et al.Journal of Vascular and Interventional Neurology|December 21, 2013
Use of intravenous recombinant tissue plasminogen activator in patients with borderline elevation of international normalized ratioHarsh R Aggarwal, Ameer E Hassan, Gustavo J Rodriguez, et al.Pageof 22